We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.7B
AUM Growth
+$669M
Cap. Flow
+$101M
Cap. Flow %
0.79%
Top 10 Hldgs %
53.96%
Holding
1,032
New
51
Increased
303
Reduced
597
Closed
72

Sector Composition

Rank Sector Weight
1 Energy 65.53%
2 Technology 4.85%
3 Healthcare 3.53%
4 Consumer Discretionary 3.46%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
301
TE Connectivity
TEL
$58.8B
$2.62M 0.02%
18,668
+355
+2% +$45.7K
OKTA icon
302
Okta
OKTA
$24.1B
$2.62M 0.02%
28,889
+4,131
+17% +$315K
AXSM icon
303
Axsome Therapeutics
AXSM
$12.4B
$2.59M 0.02%
32,482
-2,346
-7% -$157K
RYZB
304
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$2.58M 0.02%
+41,539
New +$1.03M
SHOO icon
305
Steven Madden
SHOO
$3.12B
$2.56M 0.02%
60,938
+8,576
+16% +$311K
DT icon
306
Dynatrace
DT
$12.1B
$2.44M 0.02%
44,663
-7,123
-14% -$360K
COLM icon
307
Columbia Sportswear
COLM
$3.19B
$2.42M 0.02%
30,389
+4,288
+16% +$327K
CRI icon
308
Carter's
CRI
$1.43B
$2.39M 0.02%
31,858
+4,480
+16% +$311K
NSC icon
309
Norfolk Southern
NSC
$78.8B
$2.37M 0.02%
10,043
+51
+0.5% +$10.7K
BRC icon
310
Brady Corp
BRC
$4.45B
$2.35M 0.02%
40,066
+4,520
+13% +$249K
CORT icon
311
Corcept Therapeutics
CORT
$10.2B
$2.35M 0.02%
72,360
-3,345
-4% -$91.8K
MLTX icon
312
MoonLake Immunotherapeutics
MLTX
$1.59B
$2.35M 0.02%
+38,897
New +$2M
XENE icon
313
Xenon Pharmaceuticals
XENE
$6.32B
$2.34M 0.02%
50,780
+3,431
+7% +$121K
TEAM icon
314
Atlassian
TEAM
$22B
$2.33M 0.02%
9,777
-276
-3% -$54.2K
BRK.B icon
315
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.32M 0.02%
6,500
+100
+2% +$35.1K
IMCR icon
316
Immunocore
IMCR
$1.78B
$2.28M 0.02%
33,390
-2,778
-8% -$144K
GRMN
317
Garmin
GRMN
$46.9B
$2.25M 0.02%
17,509
-1,556
-8% -$180K
YUM icon
318
Yum! Brands
YUM
$41B
$2.23M 0.02%
17,102
+84
+0.5% +$10.5K
CLNE icon
319
Clean Energy Fuels
CLNE
$447M
$2.2M 0.02%
575,195
-104,676
-15% -$382K
FAST icon
320
Fastenal
FAST
$54B
$2.16M 0.02%
66,634
-828,160
-93% -$25M
SHOP icon
321
Shopify
SHOP
$148B
$2.14M 0.02%
27,419
-5,526
-17% -$353K
TCOM icon
322
Trip.com Group
TCOM
$27.5B
$2.12M 0.02%
58,964
-1,273
-2% -$43.4K
MELI icon
323
Mercado Libre
MELI
$91.3B
$2.11M 0.02%
1,340
-215
-14% -$305K
DNLI icon
324
Denali Therapeutics
DNLI
$3.67B
$2.1M 0.02%
97,962
-3,438
-3% -$68.1K
U icon
325
Unity
U
$12.5B
$2.1M 0.02%
51,264
+3,106
+6% +$95.7K

Similar funds

ALPS Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, ALPS Advisors held 1,032 positions worth $12.7B, up 5.5% from $12B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

ALPS Advisors's Q4 2023 filing shows 51 new, 303 increased, 597 reduced and 72 closed positions. Its largest new stake was Sunoco: 9,498,706 shares worth $569M. The largest sale was Crestwood Equity Partners LP, an estimated $443M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 68% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2023 buy was Sunoco: 9,498,706 shares worth $569M.
  • ALPS Advisors added most to Cameco in Q4 2023, an estimated $34.4M increase.
  • ALPS Advisors's biggest Q4 2023 reduction was MPLX, cutting an estimated $114M.
  • ALPS Advisors fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $443M.
  • ALPS Advisors's ten largest holdings make up 54% of its $12.7B portfolio in Q4 2023.
  • ALPS Advisors opened 51 new positions and closed 72 in Q4 2023.
  • ALPS Advisors's portfolio value rose 5.5% quarter-over-quarter to $12.7B.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.